Calyx Ventures Inc.
|
|||
| Mailing Address: | Suite 2200, HSBC Building 885 West Georgia Street Vancouver, British Columbia V6C 3E8 |
Head Office Address: | Suite 2200, HSBC Building 885 West Georgia Street Vancouver, British Columbia V6C 3E8 |
| Contact Name: | Roger Forde | Principal Regulator: | British Columbia |
| Business e-mail address: | rogerf@calyxbio.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 604 880-8822 | Reporting Jurisdictions: | All provinces and territories of Canada |
| Fax Number: | 604 691-6120 | Stock Exchange: | TSX Venture |
| Date of Formation: | Jun 10 2008 | Stock Symbol: | CYX |
| Jurisdiction Where Formed: | British Columbia | Auditor: | Dale Matheson Carr-Hilton Labonte LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 13172 | Transfer Agent: | Computershare Investor Services Inc. |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
